Article

Daily Medication Pearl: Fluticasone/Salmeterol (Wixela)

Wixela Inhub is indicated for the treatment of asthma in patients 4 years of age and older and maintenance treatment of patients with chronic obstructive pulmonary disease.

Medication Pearl of the Day: Fluticasone/salmeterol (Wixela)

Indication: Wixela Inhub is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist (LABA) indicated for the treatment of asthma in patients 4 years of age and older. Maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).

Insight:

  • Dosing: For oral inhalation only. Asthma—1 inhalation of Wixela 100/50, 250/50, or 500/50 twice daily. Starting dosage is based on asthma severity. Maintenance treatment of COPD—1 inhalation of Wixela Inhub 250/50 twice daily.
  • Dosage forms: Inhaler containing a combination of fluticasone propionate (100, 250, or 500 mcg) and salmeterol (50 mcg) as a powder formulation for oral inhalation.
  • Adverse events: Upper respiratory tract infection or inflammation, pharyngitis, dysphonia, oral candidiasis, bronchitis, cough, headaches, nausea, and vomiting.
  • Mechanism of action: Fluticasone propionate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity. Salmeterol is a selective long-acting beta adrenergic agonist.
  • Manufacturer: Mylan

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit:  kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com